Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Avanos Medical Avanos First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If, at any time during this call, you require immediate assistance, please press star zero for the operator. This call is being recorded on Tuesday, May 6, 2025. I would now like to turn the conference over to Scott Gullivan. Please go ahead. Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to Avanos 2025 First Quarter Earnings Conference Call. I'm pleased to start today's call by welcoming Dave Pacitti as the new Chief Executive Officer of Avanos. Dave's extensive commercial expertise and industry knowledge have consistently driven growth and transformation throughout his career. We're excited to have Dave on board as we believe his leadership will be instrumental in advancing our strategic priorities and unlocking new opportunities for the company. I'm also pleased to introduce Jason Pickett, who was recently appointed Interim CFO and Treasurer. With more than 30 years in corporate finance and accounting, including over a decade here at Avanos, most recently as Vice President, Finance, and Treasurer, Jason's experience and deep institutional knowledge make him well-suited to serve in this interim capacity. During today's call, Dave will provide a high-level overview of our first quarter results and share his initial thoughts and observations on the business environment and our product portfolio. Jason will then share additional details on these topics, as well as an update on our transformation initiatives and our 2025 planning assumptions including the impact of tariffs. We will finish the call with ...